These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3929317)

  • 21. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
    Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
    Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the intracerebral injection technique to elucidate mechanisms of apomorphine climbing and its antagonism in the mouse.
    Costall B; Naylor RJ; Nohria V
    Psychopharmacology (Berl); 1981; 73(1):91-4. PubMed ID: 6785798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine.
    Davis AS; Jenner P; Marsden CD
    Br J Pharmacol; 1986 Jan; 87(1):129-37. PubMed ID: 3955297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of intrahippocampal administration of dopamine or apomorphine on EEG of limbic structures in the rabbit brain.
    Smialowski A
    Pol J Pharmacol Pharm; 1976; 28(6):579-85. PubMed ID: 1012981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B; Domeney AM; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat.
    Campbell A; Baldessarini RJ; Yeghiayan S
    Brain Res; 1992 Oct; 592(1-2):348-52. PubMed ID: 1360315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
    Misu Y; Goshima Y; Ueda H; Kubo T
    J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of clonidine with dopamine-dependent behaviour in rodents.
    Pycock CJ; Jenner PG; Marsden CD
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1985 Mar; 24(3):193-7. PubMed ID: 3990920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.
    Di Chiara G; Morelli M; Acquas E; Carboni E
    Arzneimittelforschung; 1992 Feb; 42(2A):231-7. PubMed ID: 1586394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat.
    Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL
    Neuropharmacology; 1985 May; 24(5):391-9. PubMed ID: 4022264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.